🇺🇸 FDA
Pipeline program

Outpatient MST/OPTION-A

1R21DA017118-01

Phase 1 other completed

Quick answer

Outpatient MST/OPTION-A for Substance-Related Disorders is a Phase 1 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Substance-Related Disorders
Phase
Phase 1
Modality
other
Status
completed

Clinical trials